Dr Jyoti Nangalia speaks to ecancer about a recent study presented at ASH 2020 regarding tracing the origin of blood cancer to early childhood, decades before diagnosis.
Dr Nangalia initially talks about what the study was about and then explains the methodology of the study. She says that in this study the bone marrow and blood samples from 10 people with Philadelphia-negative myeloproliferative neoplasms were analysed.
Dr Nangalia says when speaking of results that our preliminary findings show these cancer driver mutations were often acquired in childhood, many decades before the cancer diagnosis. She further explains the results from this study and then talks about the impact this can have on the future diagnosis and treatment of blood cancers.